Methods for increasing C1 inhibitor concentrations using interfe

Details Methods for increasing C1 inhibitor concentrations using interfe Methods for increasing C1 inhibitor concentrations using interfe

1988-09-14

1993-12-21

Draper, Garnette D.

Drug, bio-affecting and body treating compositions

Lymphokine

Interferon

424 851, 424 852, 424 854, 424 856, 604 4, A61K 3766

Patent

active

052719316

ABSTRACT:
The present invention relates to the use of interferon and/or interleukin-6 to increase intravascular C1 inhibitor concentrations in patients exhibiting or at risk for a C1 inhibitor deficiency. Therapeutic compositions containing interferon and/or interleukin-6 are also disclosed.

REFERENCES:
Fong et al., J. Immunmol., 142, 1989, pp. 2321-2324.
Jones et al., Biochem. Soc. Transactions, vol. 15, 1987, p. 638.
Hack et al., Blood, 74(5) 1989, pp. 1704-1710.
Neta et al., Lymphokine Res. 7(1) 1988, pp. 403-412.
Katz et al., J. Immunol., 1989, vol. 142(6) pp. 2041.varies.2045.
Katz et al., Arthritis Rheum, 31(11) 1988, pp. 1365-1370.
Lotz et al., J. Immunol., 139, 1987, pp. 3382-3387.
Lotz et al., J. Allerg Clin Immunol, 79, 1987, p. 194, A280.
Lappin et al., Complement 4:184, A160, 1987.
Hamilton et al., Biochem J., 242, 1987, pp. 809-815.
Zuraw et al., Complement, 4:44, A319, 1987.
Davis et al., Ann. Rev. Immunol., 6:595-628 (1988).
Proud et al., Ann. Rev. Immunol., 6:49-83 (1988).
Zuraw et al., J. Clin. Invest., 78:567-575 (1986).
Zuraw et al., J. Allerg. Clin. Immunol., 81:223, A218 (1988).
Zuraw et al., J. Allerg. Clin. Immunol., 73:155, A185 (1984).
Johnson et al., Science, 173:553-554 (1971).
Lotz et al., J. Immunol., 136:3636-3642 (1986).
Firestein et al., Arthrit. Rheum., 30:S115, E13 (1987).
Nitsche et al., Am. J. Clin. Path., 76(5):679-684 (1981).
Lockshin et al., Arthrit. Rheum., 29:1467-1472 (1986).
Lewin et al., J. Biol. Chem., 258:6415-6421 (1983).
Kaplan et al., Blood, 66:636-641 (1985).
Berrettini et al., Blood, 68:455-462 (1986).
Hugli et al., "Techniques and Significance of C3a and C5a Measurement", in Immunoassays: Clinical Laboratory Techniques for the 1980s, Nakamura et al., eds., Alan R. Liss, New York, pp. 443-460 (1980).
Kozin et al., "The Contact Activation System of Plasma", in Inflammation: Basic Principles and Clinical Correlates, Gallin et al., eds., Raven Press, Ltd., pp. 101-120 (1988).
Chenoweth et al., N. Engl. J. Med., 304:497-503 (1981).
Scott et al., Blood, 63:42-50 (1984).
Saito, Semin. Thromb. Hemostasis, 13:36-49 (1987).
Gray et al., Nature, 295:503-508 (1982).
Zoon et al., Proc. Natl. Acad. Sci. USA, 76:5601-5606 (1979).
Knight et al., Science, 207:525-526 (1980).
Stein et al., Proc. Natl. Acad. Sci. USA, 77:5716-5619 (1980).
Goeddel et al., Nucleic Acids Res., 8:4057-4073 (1980).
Hitzeman et al., Nature, 293:717-722 (1981).
Muraguchi et al., J. Immunol., 127:412-416 (1981).
Kalter et al., J. Infect. Dis., 151:1019-1027 (1985).
Gelfand et al., Medicine, 58:321-328 (1979).
Frank et al., Ann. Int. Med., 84:580-593 (1976).
Arroyave et al., J. Immunol., 177:1866-1869 (1976).
Fareed et al., Sem. Thromb. Hemostasis, 10:306-328 (1984).
Salvesen et al., J. Biol. Chem., 260:2432-2436 (1985).
Laemmli et al., Nature, 277:680-685 (1970).

Affiliated with

Also associated with

Rating

Methods for increasing C1 inhibitor concentrations using interfe does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for increasing C1 inhibitor concentrations using interfe, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for increasing C1 inhibitor concentrations using interfe will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-307498